Hangzhou Phecdamed Co., Ltd.
Clinical trials sponsored by Hangzhou Phecdamed Co., Ltd., explained in plain language.
-
Scientists track Drug's journey through healthy volunteers
Knowledge-focused CompletedThis completed early-stage study looked at how a drug called TJ0113 travels through and leaves the body. Six healthy Chinese men took a single dose with a tiny radioactive marker so researchers could measure the drug in blood, urine, and stool. The goal was to understand how the …
Phase: PHASE1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 05:30 UTC
-
New drug TJ0113 put to the test in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of a new drug called TJ0113 in 130 healthy adults. Participants took the drug as a single dose, multiple doses, or after a high-fat meal to see how the body handles it. The goal was to check for side effects and measure dr…
Phase: PHASE1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC